Early in the pandemic, most research, including our own, focused on designing drugs that could block the virus's spike protein. This was a logical first step, but as we've seen, the virus is a moving ...

SARS-CoV-2 has rampantly spread around the globe and continues to cause unprecedented loss through ongoing waves of (re)infection. Increasing our understanding of the protection against infection with ...

How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...

A visual representation of the novel in silico methodology used in the study: prediction of protein structure, molecular docking simulations, and statistical analysis of computational metrics. New ...